Recent events
Recent events tied to this brand in public sources.
Back to profile5 entries
2021
ViewRay prices public stock offering
ViewRay announced the pricing of an underwritten public offering of 12.5 million common shares at $5.60 per share, for gross proceeds of $70 million before expenses. The offering was expected to close on or about November 19, 2021, subject to customary conditions.
2019
Elekta and ViewRay announced MR-guided radiation therapy collaboration
Elekta announced that it had signed a non-binding memorandum of understanding with ViewRay to advance knowledge and application of MR-guided radiation therapy. The companies said the collaboration was subject to definitive documentation.
2019
ViewRay prices public stock offering
ViewRay announced pricing for an underwritten public offering of 41,550,000 shares at $3.13 per share, for gross proceeds of approximately $130.1 million before expenses.
2019
ViewRay and Medtronic announced a clinical collaboration memorandum
ViewRay announced that it signed a non-binding memorandum of understanding with Medtronic to enter into a clinical collaboration, including exploring clinical benefits of the MRIdian MR-guided radiation therapy system. Medtronic committed to invest in a minority interest in ViewRay, subject to a commitment agreement.
2019
ViewRay and Elekta announced a collaboration memorandum
ViewRay announced that it signed a non-binding memorandum of understanding with Elekta for collaboration to advance knowledge and use of MR-guided radiation therapy. The collaboration is subject to execution of definitive documentation.